LBA79 LENVAGIST: A multicentre, comparative, placebo (P)-controlled, double-blinded, phase II study of the efficacy of Lenvatinib (L) in patients with advanced GIST after failure of imatinib and sunitinib
Axel Le Cesne, Claire Cropet, Mehdi Brahmi, Rastislav Bahleda, Emmanuelle Bompas, Thibaud Valentin, Alice Hervieu, Olivier Bouché, Armelle Dufresne, M. Toulmonde, Kévin Bourcier, Florence Duffaud, Marc Pracht, François Bertucci, Loïc Lebellec, Antoîne Italiano, Clémence Hénon, Julien Gautier, David Pérol, Jean Yves Blay (2024). LBA79 LENVAGIST: A multicentre, comparative, placebo (P)-controlled, double-blinded, phase II study of the efficacy of Lenvatinib (L) in patients with advanced GIST after failure of imatinib and sunitinib. , 35, DOI: https://doi.org/10.1016/j.annonc.2024.08.2322.
